(Press-News.org) Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in Western countries. Metastatic liver disease more frequently develops metachronous metastasis following treatment of CRC. It was reported that hepatitis B virus (HBV) infection finally reduces the risk of intrahepatic metastasis in hepatocellular carcinoma (HCC) patients with a higher survival rate and therefore can be considered an important prognostic factor for HCC patients. Rare reports are available on the relation between HBV infection and hepatic metastasis of CRC.
A research article to be published on February 14, 2011 in the World Journal of Gastroenterology addresses this question. The authors designed a cohort study to observe the relation between HBV infection and liver metastasis of CRC.
The results showed a decrease in the percentage of metastases in the Hepatitis B virus infected group (14.2%) with respect to the control group (28.2%). In contrast, the number of patients that developed extrahepatic metastases was significantly higher than the control group, without any significant difference in the overall survival rate. Finally, the authors suggested that HBV infection in colorectal cancer patients could be used as a prognostic factor in terms of hepatic metastasis formation.
###
Reference: Qiu HB, Zhang LY, Zeng ZL, Wang ZQ, Luo HY, Keshari RP, Zhou ZW, Xu RH. HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study. World J Gastroenterol 2011; 17(6): 804-808 http://www.wjgnet.com/1007-9327/full/v17/i6/804.htm
Correspondence to: Rui-Hua Xu, MD, PhD, Professor of Medical Oncology, Vice President, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China. xurh@sysucc.org.cn
Telephone: +86-20-87343468 Fax: +86-20-87343228
About World Journal of Gastroenterology
World Journal of Gastroenterology (WJG), a leading international journal in gastroenterology and hepatology, has established a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection and provides a forum for both clinicians and scientists. WJG has been indexed and abstracted in Current Contents/Clinical Medicine, Science Citation Index Expanded (also known as SciSearch) and Journal Citation Reports/Science Edition, Index Medicus, MEDLINE and PubMed, Chemical Abstracts, EMBASE/Excerpta Medica, Abstracts Journals, Nature Clinical Practice Gastroenterology and Hepatology, CAB Abstracts and Global Health. ISI JCR 2009 IF: 2.092. WJG is a weekly journal published by WJG Press. The publication dates are the 7th, 14th, 21st, and 28th day of every month. WJG is supported by The National Natural Science Foundation of China, No. 30224801 and No. 30424812, and was founded with the name of China National Journal of New Gastroenterology on October 1, 1995, and renamed WJG on January 25, 1998.
HBV infection decreases risk of liver metastasis in colorectal cancer patients
2011-03-09
ELSE PRESS RELEASES FROM THIS DATE:
Study of 90 animals' thigh bones reveals how they can efficiently carry loads
2011-03-09
The structures inside animals' thigh bones that enable them to support huge loads whilst being relatively lightweight are revealed in research published today in the journal Proceedings of the Royal Society B. The researchers say their work could lead to the development of new materials based on thigh bone geometry.
A team from Imperial College London and the Royal Veterinary College collected thigh bone samples from British museum collections and zoos, analysing specimens of the femur bone from 90 different species including the Asian elephant, Etruscan shrew, roadrunner, ...
Laughter really is the best medicine (for leg ulcers)
2011-03-09
Forget technology. The best prescription for patients with venous leg ulcers is good quality nursing care – and the occasional belly laugh!
A five-year study led from the University of Leeds has shown that ultrasound therapy does nothing to speed up the healing process of leg ulceration – contrary to what had been expected. Traditional methods of nursing care, which are cheaper and easier to deliver, work just as well, the authors conclude.
"The 'healing energy' of low-dose ultrasound can make a difference to some medical conditions but with venous leg ulcers, this ...
Roundworm could provide new treatment for sepsis
2011-03-09
Research by the University of Liverpool has found that systemic inflammation caused by sepsis can be suppressed by a protein which occurs naturally in a type of roundworm.
Sepsis is a serious inflammatory condition, caused by the body over-reacting to infection. The body becomes overwhelmed by bacteria, setting off a series of reactions that lead to inflammation and clotting. It affects around 20 million people worldwide each year, and accounts for a large proportion of intensive care unit admissions.
For the past 30 years, sepsis has largely been treated by antibiotics ...
Big games, close scores lead to more auto fatalities for winning fans
2011-03-09
Closely contested major sporting events are followed by a significant increase in traffic fatalities for fans of the winning team, according to new research from North Carolina State University. It turns out there may be more on the line than many sports fans bargained for.
"A previous study showed that traffic fatalities increased in the hours following the Super Bowl. We wanted to see if that held true for other high-profile sporting events and, if so, whether the number of fatalities was influenced by whether the game was a close one," says Dr. Stacy Wood, Langdon ...
Rituximab combined with a TNF inhibitor and methotrexate shows no safety signal in RA treatment
2011-03-09
A recent trial of rituximab in combination with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) found the safety profile to be consistent with other RA trials with TNF inhibitors. While the trial reported no new safety risks, clear evidence of an efficacy advantage in RA patients receiving the combination therapy was not observed in this study sample. Results of the trial are published in the March issue of Arthritis & Rheumatism, a peer-reviewed journal of the American College of Rheumatology.
The National ...
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis
2011-03-09
Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects. Full findings are available in the March issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Raynaud's ...
Scanning antiquity underfoot
2011-03-09
According to rough estimates, there are some 20,000 undiscovered archaeological sites in Israel waiting to be explored. Currently buried under highways or beneath cities, some could reveal historic monuments from the biblical past and give us clues to the expansion and settlement of modern man as he made his way through the Fertile Crescent.
But where to begin? Who decides which sites should be "dug" — at considerable financial cost — and which should remain unexplored until a later date? A new tool from Prof. Lev Eppelbaum of Tel Aviv University's Department of Geophysics ...
New bowel cancer evidence calls for routine DNA repair test
2011-03-09
Bowel cancer patients whose tumors contain defects in specific DNA repair systems are much less likely to experience tumour recurrence post surgery, results from a major clinical study have demonstrated.
Scientists who collaborated on the 10 year QUASAR randomised control trial, one of the largest UK clinical trials to test the benefits of chemotherapy in post-surgery bowel cancer patients, have confirmed that colon tumors containing defects in their DNA mismatch repair system are 50 percent less likely to recur following surgery compared to tumors where DNA mismatch ...
Malaria's weakest link
2011-03-09
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Santé et de la Recherche Médicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
The research, published online in the journal Cellular Microbiology, shows that the malaria parasite depends upon a signaling pathway ...
Study: Homeless patients cost $2,500 more than the average patient for each hospital stay
2011-03-09
TORONTO, ON., March 8, 2011—Homeless patients cost about $2,500 more per hospital stay than the average patient, according to a new study by researchers at St. Michael's Hospital.
Homeless people with medical or surgical problems arrive at the hospital with underlying health issues and stay longer than others, often because there is no place to send them after their initial medical crisis has been treated, the study found. Those with psychiatric illness arrive at the hospital much sicker than others.
The findings suggest the cost of hospitalizing people who are homeless ...